Examples of using Arepanrix in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
How does Arepanrix work?
Arepanrix is a vaccine that is given by injection.
How to store Arepanrix.
How Arepanrix is given.
Emulsion for emulsion for injection for Arepanrix.
Arepanrix may be used in lactating women.
Suspension for emulsion for injection for Arepanrix.
Arepanrix is a vaccine against a pandemic influenza flu.
You should discuss with your doctor whether you should receive Arepanrix.
Arepanrix should under no circumstances be administered intravascularly.
There are currently no data available on the use of Arepanrix in pregnancy.
Arepanrix is given as one dose, injected into the shoulder muscle.
Immune response to Arepanrix(H1N1) in adults aged 18-60 years.
Arepanrix contains a flu strain called A/California/7/2009(H1N1) v-like strain X-179A.
There are no data on co-administration of Arepanrix with other vaccines.
As with all vaccines, Arepanrix may not fully protect all persons who are vaccinated.
Persons who have received a seasonal influenza vaccine that does not contain an adjuvant may receive Arepanrix after an interval of at least three weeks.
Both contain the same adjuvant, In Arepanrix, a different method is used to prepare the haemagglutinins used in the vaccine.
The Applicant/MAH shall agree with Member States on mechanisms allowing patients andhealth care professionals to have continuous access to updated information regarding Arepanrix.
The company that makes Arepanrix will collect information on the safety of the vaccine while it is being used.
Clinical studies have evaluated the incidence of adverse reactions in approximately 4,500 subjects 18 years old andabove who received a version of Arepanrix containing 3.75 microgram HA derived from A/Indonesia/5/2005 H5N1.
Arepanrix contains small amounts of haemagglutinins(proteins from the surface) of a virus called A(H1N1)v that is causing the current pandemic.
Three clinical studies have evaluated the immunogenicity of a version of Arepanrix containing 3.75 µg HA derived from A/Indonesia/05/2005(H5N1) in subjects from the age of 18 years onwards following a 0, 21 days schedule.
Arepanrix is very similar to another pandemic vaccine called Pandemrix, which has been available in the European Union(EU) since September 2009.
In a clinical study that evaluated immunogenicity in healthy subjects aged 18-60 years who received either Arepanrix(H1N1)(N=167) or an AS03-containing vaccine containing HA from H1N1v manufactured using a different process(N=167), the anti-HA antibody responses 21 days after a first dose were as follows.
Because Arepanrix is similar to Pandemrix, the company used the data on the use of Pandemrix in children to support the use of Arepanrix in children.
Therefore the data indicate that Arepanrix may be administered three weeks after the administration of non-adjuvanted seasonal influenza vaccines.
Arepanrix should not be given to people who have had an anaphylactic reaction(severe allergic reaction) to any of the components of the vaccine, or to any of the substances found at trace levels in the vaccine, such as egg or chicken protein, ovalbumin(a protein in egg white), formaldehyde and sodium deoxycholate.
Therefore the data indicate that Arepanrix may be co-administered with non-adjuvanted seasonal influenza vaccines with injections made into opposite limbs.
The studies of Arepanrix H5N1 showed that the vaccine was able to bring about protective levels of antibodies in at least 70% of people in which it was studied.